(2S,3S)-2,3-BIS((4-METHYLBENZOYL)OXY)BUTANEDIOIC ACID, ETHYL ACETATE AND METHYL (4S)-8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE (1:1:1)
UNII BBN35P2CJ3
Substance Identification & Data
This profile provides standardized clinical and technical data for (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)butanedioic Acid, Ethyl Acetate And Methyl (4s)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate (1:1:1), uniquely identified by the FDA Unique Ingredient Identifier (UNII) BBN35P2CJ3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2244994-24-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H30F4N4O4.C20H18O8.C4H8O2 CTUAAPGOFXTEJK-KPXZVEDASA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)butanedioic Acid, Ethyl Acetate And Methyl (4s)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate (1:1:1). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.